10
May

In April, Synpromics attended the 6th annual Alliance for Regenerative Medicine Cell & Gene Therapy Investor Day in New York, a full-day conference featuring discussi

15
Mar
ASGCT banner

As product developers move toward 2nd generation gene and cell medicine constructs, the importance of novel gene regulation and promoter elements has emerged.

12
Mar
BioCentury Innovations

Bringing synthetic biology to transcriptional regulation could catalyse a new generation of gene therapies that are more tunable, disease-specific and easy to deliver than the products dominating the field.

23
Feb
medical expo e magazine

Artificial Intelligence is a hot topic of conversation in pretty much every industry all the way from manufacturing to education.

26
Jan
MedNous

The past decade has seen a resurgence in the field of cell and gene therapy, with three treatments being approved by the European Medicines Agency and the US Food and Drug Administration and a flood of candidate therapies

Pages